Cargando…

Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease

Currently, neurodegenerative diseases are a major cause of disability around the world. Parkinson’s disease (PD) is the second-leading cause of neurodegenerative disorder after Alzheimer’s disease. In PD, continuous loss of dopaminergic neurons in the substantia nigra causes dopamine depletion in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prasad, E. Maruthi, Hung, Shih-Ya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602991/ https://www.ncbi.nlm.nih.gov/pubmed/33081318 http://dx.doi.org/10.3390/antiox9101007

Ejemplares similares

Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
por: Prasad, E. Maruthi, et al.
Publicado: (2021)

Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
por: Zeng, Xian-Si, et al.
Publicado: (2018)

Neurogenesis in Neurotoxin-induced Animal Models for Parkinson’s Disease—A Review of the Current Status
por: He, Xi Jun, et al.
Publicado: (2009)

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal
por: Mou, Ya-Kui, et al.
Publicado: (2022)

Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Zhao, Xin, et al.
Publicado: (2013)

On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
por: Segura-Aguilar, Juan
Publicado: (2017)

Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease
por: Ren, Rutong, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Parkinson’s Disease: A Critical Appraisal
por: Jost, Wolfgang H.
Publicado: (2021)

Botulinum Neurotoxin for Pain Management: Insights from Animal Models
por: Pavone, Flaminia, et al.
Publicado: (2010)

Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson’s Disease: An Updated Review
por: Mitchell, Steven D., et al.
Publicado: (2021)

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
por: Luvisetto, Siro
Publicado: (2021)

Toxin-Induced and Genetic Animal Models of Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2010)

Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s Disease
por: Chinta, Shankar J., et al.
Publicado: (2018)

Animal Model for Prodromal Parkinson’s Disease
por: Taguchi, Tomoyuki, et al.
Publicado: (2020)

Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease
por: Chiu, Ya-Jen, et al.
Publicado: (2023)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Neuroprotective effect of Ginsenoside Re against neurotoxin-induced Parkinson's disease models via induction of Nrf2
por: Qiao, Juhui, et al.
Publicado: (2022)

Lipopolysaccharide Animal Models for Parkinson's Disease
por: Liu, Mei, et al.
Publicado: (2011)

Limitations of Animal Models of Parkinson's Disease
por: Potashkin, J. A., et al.
Publicado: (2010)

Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson’s Disease Differently Affects Behavior
por: Antipova, Veronica A., et al.
Publicado: (2017)

Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson’s disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation
por: Li, Yang, et al.
Publicado: (2023)

Classic and New Animal Models of Parkinson's Disease
por: Blesa, Javier, et al.
Publicado: (2012)

NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
por: Anantha, Jayanth, et al.
Publicado: (2021)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
por: Martinez, Bridget, et al.
Publicado: (2018)

Animal Models for Parkinson’s Disease Research: Trends in the 2000s
por: Kin, Kyohei, et al.
Publicado: (2019)

Parkinson’s Disease: Exploring Different Animal Model Systems
por: Khan, Engila, et al.
Publicado: (2023)

Animal Models of Parkinson's Disease
por: Imai, Yuzuru, et al.
Publicado: (2011)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Rapid Microfluidic Assay for the Detection of Botulinum Neurotoxin in Animal Sera
por: Babrak, Lmar, et al.
Publicado: (2016)

Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease
por: Fujita, Kyota, et al.
Publicado: (2011)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
por: Blaudin de Thé, François-Xavier, et al.
Publicado: (2016)

Animal Model for Lower Urinary Tract Dysfunction in Parkinson’s Disease
por: Kitta, Takeya, et al.
Publicado: (2020)

Photobiomodulation for Parkinson’s Disease in Animal Models: A Systematic Review
por: Salehpour, Farzad, et al.
Publicado: (2020)

Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models
por: Muksuris, Katherine, et al.
Publicado: (2023)

Animal Models of Autosomal Recessive Parkinsonism
por: Bastioli, Guendalina, et al.
Publicado: (2021)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson's disease
por: Dadgar, Masoumeh, et al.
Publicado: (2018)

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease
por: Deng, Isaac, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ofa1oqh8dumgiulvojg04vphh9